As a global leader in blood component, therapeutic apheresis and cellular technologies, we believe in the potential of blood to do even more for patients than it does today.

This belief inspires our innovation and strengthens our collaboration with customers.

Working together with our customers, we can make safer, higher-quality transfusions available to more people. We can bring even more treatment options to patients through advanced blood therapies. And we can make the dream of new, cutting-edge blood and cell therapies the new standard of care. Our work has the potential to fundamentally improve health care.

We are guided by our customers' needs, aspirations and ongoing drive to improve efficiency and patient outcomes.